What 13 Analyst Ratings Have To Say About HCA Healthcare
Portfolio Pulse from Benzinga Insights
Within the last quarter, HCA Healthcare (NYSE:HCA) received 13 analyst ratings: 4 bullish, 6 somewhat bullish, and 3 indifferent. The average price target is $282.69, which is higher than the current price of $258.5, but this target has decreased by 9.04% from the previous target of $310.80. Analysts rate stocks based on future earnings potential and company risk, typically updating their ratings quarterly or after significant company events.
December 11, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HCA Healthcare has an average analyst price target of $282.69, suggesting an upside from the current price, but the target has been reduced from $310.80, indicating potential analyst concern.
The mixed analyst ratings with a majority leaning towards bullish and somewhat bullish suggest a cautiously optimistic view. The decrease in the average price target may reflect a reassessment of HCA's future earnings potential or perceived risks, which could lead to short-term uncertainty in the stock's performance. However, the fact that there are no bearish ratings could mitigate negative impact.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100